Alzamend Neuro, Inc. (ALZN) [Rocket]

In millions, except per share items	Apr-30-23	Jan-31-23	Oct-31-22	Jul-31-22	Apr-30-22	Jan-31-22	Oct-31-21	Jul-31-21
	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q
Assets
Cash and equivalents	5.1	7.4	9.2	11.5	14.1	11.8	13.6	15.6
Other current assets	0.7	1.0	1.2	0.6	0.3	0.6	0.9	1.2
Total current assets	5.8	8.4	10.3	12.1	14.4	12.4	14.5	16.8
Property, plant, and equipment, net	0.1	0.1	0.1	0.1	0.1
Total assets	5.9	8.5	10.4	12.2	14.5	12.4	14.5	16.8

Accounts payable	2.9	2.6	0.6	1.0	1.2	0.5	1.1	1.1
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other current liabilities			1.0		0.0	0.0	0.3	0.4
Total current liabilities	2.9	2.6	1.6	1.0	1.2	0.5	1.5	1.5
Long-term debt							0.3	0.3
Total liabilities	2.9	2.6	1.6	1.0	1.2	0.5	1.8	1.8

Shareholders' equity [+]	3.0	5.9	8.8	11.2	13.4	12.0	12.7	15.0
Paid-in capital	62.0	61.5	59.0	58.3	57.4	52.2	50.7	49.4
Retained earnings	0.0	0.0	-35.3	-32.2	0.0	-25.3	-22.8	-19.2
Tangible shareholders' equity	3.0	5.9	8.8	11.2	13.4	12.0	12.7	15.0